Aurobindo Pharma bets big on antibiotic self-reliance

New Delhi: Aurobindo Pharma expects its Penicillin-G (Pen-G) production to exceed 10,000 metric tonnes on an annualised basis over the next 12 months, according to CFO S Subramanian. Speaking to analysts, he said the ramp-up at the company’s Pen-G facility in the Kakinada SEZ in Andhra Pradesh is progressing as planned, with yields steadily improving. Over time, the facility is expected to reach a capacity of 15,000 metric tonnes per annum. Subramanian said the government’s decision to grant a one-year relaxation on the minimum import price for Pen-G, 6-APA and Amoxicillin is a key positive catalyst, supporting domestic API manufacturing, reducing supply risks and strengthening India’s antibiotic self-reliance.